Ben Gust - Profile and Investment Details

Investor Profile

Ben Gust is a Micro VC based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as Spinifex Pharmaceuticals Pty Ltd, Neuromonics, Peplin, Phenomix, Nuon Therapeutics, Moximed, Mimetica Pty Ltd, XenomeElastagen, Spinifex Pharmaceuticals, Verva Pharmaceuticals, JET Charge, Sunman Energy, Hatchtech, Omni Tanker Pty Ltd, CHF Solutions, Ocunexus Therapeutics, Clean Energy Finance Corporation, Humanigen, GreenSync Pty Ltd, Hatchtech Pty Ltd, OPAL Therapeutics, AIMEDICS, health.com.au, Hydrexia, Applied Physiology, Ivantis, Inc, Viveve, Hydrexia Pty Ltd, Pathway Therapeutics, Neurovance, Celladon, NovaSys, Uptake Medical, AirXpanders, ChemGenex Pharmaceuticals, NeuroVista, NOVASYS MEDICAL, Ivantis, Proacta, Euthymics Bioscience, . Over time, Ben Gust has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ben Gust is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Transportation, Energy, Technology, Manufacturing, Biotechnology, Neuroscience, Clinical Trials, Semiconductor Tech, Logistics, Utilities, Health Diagnostics, Hydrogen Technology, Renewable Energy, Medical, B2B, Pharmaceuticals may find it worthwhile to explore potential connections with Ben Gust, as their portfolio suggests a familiarity and interest in this area.

Understanding Ben Gust’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.